Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jan;117(2):236–237. doi: 10.1111/j.1476-5381.1996.tb15181.x

Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in the rat.

A Kawabata 1
PMCID: PMC1909262  PMID: 8789373

Abstract

This study investigated the effect of prolonged inhibition of nitric oxide (NO) synthase on plasma fibrinogen levels and platelet count in the rats. NG-nitro-L-arginine methyl ester (L-NAME), when administered orally twice a day, at 10-100 mg kg-1, for 7 consecutive days, 14 times in all, significantly elevated fibrinogen levels and systolic blood pressure in a dose-dependent manner. The same dose range of L-NAME failed to alter platelet count and plasma protein concentrations. The increase in fibrinogen levels produced by chronic treatment with L-NAME at 30 mg kg-1 was reversed by L-arginine at 500-1500 mg kg-1 in a dose-dependent manner. These findings suggest that endogenous NO tonically acts to reduce plasma fibrinogen levels in rats under physiological conditions.

Full text

PDF
236

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kawabata A., Hata T. Possible involvement of oxygen-derived free radicals in abnormal hemostasis induced by SART stress (repeated cold stress) in laboratory animals. Thromb Res. 1993 Nov 15;72(4):321–331. doi: 10.1016/0049-3848(93)90141-a. [DOI] [PubMed] [Google Scholar]
  2. Kawabata A., Manabe S., Manabe Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol. 1994 Jun;112(2):547–550. doi: 10.1111/j.1476-5381.1994.tb13108.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Korbut R., Warner T. D., Gryglewski R. J., Vane J. R. The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats. Br J Pharmacol. 1994 May;112(1):289–291. doi: 10.1111/j.1476-5381.1994.tb13066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lidbury P. S., Korbut R., Vane J. R. Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol. 1990 Nov;101(3):527–530. doi: 10.1111/j.1476-5381.1990.tb14115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. May G. R., Crook P., Moore P. K., Page C. P. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol. 1991 Mar;102(3):759–763. doi: 10.1111/j.1476-5381.1991.tb12246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Molnár M., Sütö T., Tóth T., Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994 May;170(5 Pt 1):1458–1466. doi: 10.1016/s0002-9378(94)70179-2. [DOI] [PubMed] [Google Scholar]
  7. Tranquille N., Emeis J. J. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor. Thromb Haemost. 1993 Mar 1;69(3):259–261. [PubMed] [Google Scholar]
  8. Wright C. E., Rees D. D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 1992 Jan;26(1):48–57. doi: 10.1093/cvr/26.1.48. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES